Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan

NCT02756819 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02756819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02756819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
July 18, 2016
Completion date
May 8, 2018
Enrollment
1,945 (actual)
Sites
66

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension